Conference Calls & Webcasts

Latest Webcast

11/20/2014 - Webcast: Jefferies 2014 Global Healthcare Conference

Jens Holstein present at the Jefferies 2014 Global Healthcare Conference, London, UK, on November 20, 2014, 1:40pm GMT (8:40am EST, 2:40pm CET)

Go to Webcast...

Archive

06/06/2013 - Webcast: Jefferies 2013 Global Healthcare Conference, New York, USA

Dr. Simon Moroney, CEO of MorphoSys AG, presented the Company at the Jefferies 2013 Global Healthcare Conference in New York, USA, on June 6, 2013.

Go to Webcast...

06/03/2013 - Conference Call: MorphoSys Signs Global License Agreement with GlaxoSmithKline for MOR103 Program

On June 3 2013, MorphoSys announced that they have entered into a global agreement with GlaxoSmithKline (GSK) to develop and commercialize MOR103.

MorphoSys held a public conference call to present more information on the agreement.

05/03/2013 - Conference Call and Webcast: Q1 2013 Results

MorphoSys AG published its first three months’ 2013 results on May 3, 2013.

During a public conference call and webcast, the Management Board of MorphoSys AG presented MorphoSys’s financial results for the first three months of 2013 and provided further details on the Company’s latest developments.

03/14/2013 - Barclays Global Healthcare Conference 2013

Jens Holstein, CFO of MorphoSys AG, presented the Company at the Barclays Global Healthcare Conference in Miami, FL, USA, on Thursday, March 14, 2013.

Go to Webcast...

03/05/2013 - Year End 2012 and Q4 Results

MorphoSys published its Annual Financial Results 2012 on March 5, 2013. In conjunction with that, the Company held a conference call to further discuss the financial and operational results.

01/10/2013 - Webcast: J.P. Morgan Healthcare Conference

Dr. Simon Moroney, CEO of MorphoSys AG, presented the Company at the J.P. Morgan Healthcare Conference in San Francisco, USA, on Thursday, January 10, 2013.

 Go to Webcast...

Conference Call and Webcast: Bio-Rad plans Acquisition of MorphoSys’s Research and Diagnostic Antibody Business AbD Serotec

On December 17, 2012 the Management Board of MorphoSys AG hosted a public conference call and webcast to present information on Bio-Rad’s planned Acquisition of MorphoSys’s Research and Diagnostic Antibody Business AbD Serotec.

11/15/2012 - Webcast: Jefferies Global Healthcare Conference

Jens Holstein, CFO of MorphoSys AG, presented the Company at the Jefferies Global Healthcare Conference in London, UK, on November 15, 2012 at 2:20 pm GMT (9:20 am EST, 3:20 pm CET).

 

11/07/2012 - Conference Call and Webcast: Q3 2012 Results

MorphoSys AG published its first nine months’ 2012 results on November 7, 2012.

During a public conference call and webcast, the Management Board of MorphoSys AG presented MorphoSys’s financial results for the first nine months of 2012 and provided further details on the Company’s latest developments.

09/21/2012 - Conference Call and Webcast: Clinical Trial Results of MOR103 in Rheumatoid Arthritis

On September 21, 2012, the Management Board of MorphoSys AG hosted a public conference call and webcast to present information on the results of the clinical phase 1b/2a trial of MorphoSys's proprietary antibody MOR103 in patients with rheumatoid arthritis, which was announced the day before.